Bridging Cancer Care for Underserved Patients with Veris Health Platform

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to optimize and validate the Veris Health Cancer Care Platform for medically underserved cancer patients undergoing outpatient therapy. It will use user-centered design and partner with community health centers to ensure cultural and linguistic suitability and ease of use. A mixed-methods approach will combine quantitative data analysis with qualitative interviews of patients and providers to assess effectiveness during high-risk periods. The study focuses on patients facing language barriers, limited technology access, and socioeconomic disparities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults \> 18 years old
* Diagnosis of cancer
* ECOG Performance Status of 0-2
* Undergoing or initiating systemic anticancer therapy
* Able to utilize and interact with a mobile application and in-home devices for physiological monitoring. Have at least one of the following barriers to healthcare access: Spanish as primary language, uninsured, insured with Medicaid, dual eligible for Medicare and Medicaid

Exclusion Criteria:

-N/A

Where it's running

• The Ohio State University
  Columbus, Ohio, United States Recruiting

Study contacts

• Study coordinator: Brian deGuzman MD COO
• Email: bjd@verishealth.com
• Phone: 917-813-1828

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients

  This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07807943

• Project VERANDA — a survey about barriers and privacy concerns to seeking help

  An anonymous questionnaire for adults to see what barriers, privacy worries, and attitudes make people with sexual interest in children more or less likely to seek treatment.

  Recruiting Berlin Institute of Health @ Charité · Berlin, State of Berlin · NCT07424872

• Iruplinalkib for ALK-positive advanced lung adenocarcinoma after lorlatinib

  We will try iruplinalkib in adults with advanced ALK-positive lung adenocarcinoma who progressed on or couldn't tolerate lorlatinib to see how well it works and how safe it is in routine care.

  Recruiting Peking University Shenzhen Hospital · Shenzhen, Guangdong · NCT07374614

• A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus

  This project will test whether a new prediction model can guide treatment choices to improve survival for adults with renal cell carcinoma, including those with venous tumor thrombus.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07117227

• Understanding the progression of Sialidosis Type I

  This study is trying to understand how Sialidosis Type I affects people by checking their brain and eye health regularly to see how the condition changes over time.

  Recruiting National Taiwan University Hospital · Taipei, Taipei · NCT06316752

• Risk-score predictor for dementia in older adults with depression

  This study tests whether a point-based risk score from electronic medical records can accurately predict which older adults with depression will develop dementia.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang, Jiangxi · NCT07676851

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.